Philipp M. Rößner
Hat mitgewirkt an:
-
Characterization of T-cells in Chronic lymphocytic leukemia and their modulation by clinically-approved targeted therapies with PI3Kdelta inhibitors
-
Phosphoinositide 3-kinase signaling in the tumor microenvironment: what do we need to consider when treating chronic lymphocytic leukemia with PI3K inhibitors?
-
TBET‐expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice
-
EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia